|| generic epclusa india is a pangenotypic (universal) drug in the treatment of HCV, as it cures any virus genotypes with the same high efficiency (95–98%). On the pharmaceutical market is in high demand, as it cures not only any genotype of the virus, but also completely relieves patients from active and chronic forms of HCV.
After undergoing treatment using Generic Epclusa, patients completely get rid of the disease, returning to a full life. Being the generic (analogue) of the drug Epclusa, developed and manufactured by the pharmaceutical giant Gilead Sciences, the Indian analogue is completely identical to the American original.
Full coincidence is both in the composition of the active components, and in the effectiveness of the therapeutic effect on patients with HCV. There is only one difference: ceteris paribus, sofosbuvir velpatasvir price is several times cheaper than Epclusa, which is due to increased demand.